Molecular Biology of the Cell track citations

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Savagner, P.
Right arrow Articles by Thiery, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Savagner, P.
Right arrow Articles by Thiery, J. P.

Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells

P Savagner, AM Valles, J Jouanneau, KM Yamada and JP Thiery

Laboratoire de Physiopathologie du Developpement, Centre National de la Recherche Scientifique-Ecole Normale Superieure, Paris, France.

We described previously that acidic fibroblast growth factor (aFGF), but not basic fibroblast growth factor (bFGF), can induce the rat carcinoma cell line NBT-II to undergo a rapid and reversible transition from epithelial to mesenchymal phenotype (EMT). We now find that NBT-II EMT is stimulated by keratinocyte growth factor (KGF) in cells grown at low density. Accordingly, a high-affinity receptor showing 98% homology to mouse FGF receptor 2b/KGF receptor was cloned and sequenced from NBT- II cells. Northern analysis indicated that mRNA for FGF receptor 2b/KGF receptor was drastically down-regulated within 1 wk in aFGF-induced mesenchymal NBT-II cells. This decrease coincided with an up-regulation of FGF receptor 2c/Bek, a KGF-insensitive, alternatively spliced form of FGF receptor 2b/KGF receptor. Functional studies confirmed that KGF could not maintain EMT induction on mesenchymal NBT-II cells. FGF receptor 1 and FGF receptor 2c/Bek could also support EMT induction when transfected into NBT-II cells in response to aFGF or bFGF. Such transfected cells could bind bFGF as well as aFGF. Therefore, EMT can be induced through different FGF receptors, but EMT may also regulate FGF receptor expression itself.

Volume 5, Issue 8, pp. 851-862, 08/01/1994
Copyright © 1994 by The American Society for Cell Biology




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Oltean, B. S. Sorg, T. Albrecht, V. I. Bonano, R. M. Brazas, M. W. Dewhirst, and M. A. Garcia-Blanco
Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity
PNAS, September 19, 2006; 103(38): 14116 - 14121.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. P. Baraniak, J. R. Chen, and M. A. Garcia-Blanco
Fox-2 Mediates Epithelial Cell-Specific Fibroblast Growth Factor Receptor 2 Exon Choice
Mol. Cell. Biol., February 15, 2006; 26(4): 1209 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Steiling, M. Muhlbauer, F. Bataille, J. Scholmerich, S. Werner, and C. Hellerbrand
Activated Hepatic Stellate Cells Express Keratinocyte Growth Factor in Chronic Liver Disease
Am. J. Pathol., October 1, 2004; 165(4): 1233 - 1241.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C. Billottet, N. Elkhatib, J.-P. Thiery, and J. Jouanneau
Targets of Fibroblast Growth Factor 1 (FGF-1) and FGF-2 Signaling Involved in the Invasive and Tumorigenic Behavior of Carcinoma Cells
Mol. Biol. Cell, October 1, 2004; 15(10): 4725 - 4734.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Nakajima, R. Doi, E. Toyoda, S. Tsuji, M. Wada, M. Koizumi, S. S. Tulachan, D. Ito, K. Kami, T. Mori, et al.
N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
Clin. Cancer Res., June 15, 2004; 10(12): 4125 - 4133.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Mareel and A. Leroy
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Physiol Rev, April 1, 2003; 83(2): 337 - 376.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. BAILLY, F. SOULET, D. LEROY, F. AMALRIC, and G. BOUCHE
Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor
FASEB J, February 1, 2000; 14(2): 333 - 344.
[Abstract] [Full Text]


Home page
J. Cell Biol.Home page
M. T. Nieman, R. S. Prudoff, K. R. Johnson, and M. J. Wheelock
N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of their E-Cadherin Expression
J. Cell Biol., November 1, 1999; 147(3): 631 - 644.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Tanahashi, M. Suzuki, T. Imamura, and Y. Mitsui
Identification of a 79-kDa Heparin-binding Fibroblast Growth Factor (FGF) Receptor in Rat Hepatocytes and Its Correlation with the Different Growth Responses to FGF-1 between Hepatocyte Subpopulations
J. Biol. Chem., April 5, 1996; 271(14): 8221 - 8227.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]